Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Journal of Southern Medical University》 2006-11
Add to Favorite Get Latest Update

Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma

XU Zhuo-ming1,WANG Jun-hua1,ZHEN Zuo-jun1,CHEN Huan-wei1,CUI Wei-zhen2 1Department of Hepatobiliary Surgery,2Department of Ultrasonography,First People's Hospital of Foshan City,Foshan 528000,China  
Objective To explore the value of percutaneous radiofrequency ablation(PRFA) combined with transcatheter arterial chemoembolization(TACE) and percutaneous ethanol injection(PEI) in the management of recurrent small hepatocellular carcinoma.Methods Between March 2001 and March 2005,52 patients with recurrent hepatocellular carcinoma(tumor size≤5 cm) underwent PRFA,and 14 of the patients(tumor size 3-5 cm) also received TACE and PEI,and their clinical data were analyzed retrospectively.Results MRI or CT after PRFA revealed complete coagulative necrosis of the tumor in 38 cases(tumor size 3 cm).In the 14 patients(tumor size 3-5 cm) with also TACE and PEI,complete necrosis occurred in 11 cases(78.6%).In the patients involved in this study,the 1-,2-,3-and 4-year survival rates were 96.2%,69.4%,45.5% and 30.0%,respectively.Conclusions PRFA is an effective modality for local treatment of recurrent small hepatocellular carcinoma,capable of total elimination of tumors 3 cm.For tumors of 3-5 cm,combination with TACE and PEI may help increase the tumor necrosis rate following the ablation and raise the patients' survival rate.
【Fund】: 佛山市重点科技攻关项目(0208018)~~
【CateGory Index】: R735.7
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved